Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Sue worked in the Department of Immunology, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences at Monash University as a Senior Research Manager/Senior Research Fellow. The broad goal of her work is to develop nanovaccines for infectious diseases and cancer. More specifically, 1) investigate nanoparticles (such as polymeric particles, solid core nanoparticles, magnetic nanoparticles etc.) and their functions in immunomodulations and vaccine delivery; 2) develop vaccine and immunotherapy for the treatment of ovarian cancer. Her current research profile see link here: http://hudson.org.au/researcher-profile/sue-xiang/

Research area keywords

  • Ovarian cancer
  • Biomarkers
  • Nanoparticles
  • Adjuvants
  • Vaccines
  • Nanocarrier
  • Monoclonal antibodies
  • Immunology
  • Immunotherapy

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria

Wilson, K. L., Pouniotis, D., Hanley, J., Xiang, S. D., Ma, C., Coppel, R. L. & Plebanski, M., 15 Mar 2019, In : Frontiers in Immunology. 10, 12 p., 331.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
1 Citation (Scopus)

Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 + T Cell Responses

Xiang, S. D., Wilson, K. L., Goubier, A., Heyerick, A. & Plebanski, M., 1 Dec 2018, In : Frontiers in Immunology. 9, 17 p., 2968.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities

Kampan, N. C., Xiang, S. D., McNally, O. M., Stephens, A. N., Quinn, M. A. & Plebanski, M., 1 Jan 2018, In : Current Medicinal Chemistry. 25, 36, p. 4785-4806 22 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

14 Citations (Scopus)

Sperm protein 17 expression by murine epithelial ovarian cancer cells and its impact on tumor progression

Gao, Q., Xiang, S. D., Wilson, K., Madondo, M., Stephens, A. N. & Plebanski, M., 20 Aug 2018, In : Cancers. 10, 8, 15 p., 276.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
4 Citations (Scopus)

Design of nanoparticle structures for cancer immunotherapy

Tsirikis, P., Xiang, S. D., Selomulya, C. & Plebanski, M., 14 Apr 2017, Nanostructures for Cancer Therapy. Ficai, A. & Grumezescu, A. M. (eds.). Amsterdam Netherlands: Elsevier, p. 307-328 22 p. (Nanostructures in Therapeutic Medicine Series; vol. 4).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review